Stéphane Gennai | Medicine and Health Sciences | Innovative Research Award

Published on by Top Teachers

Innovative Research Award

Stéphane Gennai
Researcher, University of Reims Champagne-Ardenne (Reims University Hospital), France

Stéphane Gennai
Affiliation University of Reims Champagne-Ardenne (Reims University Hospital)
Country France
Scopus ID 23093862000
Documents 55
Citations 1,267
h-index 14
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-8490-4706

Stéphane Gennai is a French emergency medicine physician and university professor affiliated with the University of Reims Champagne-Ardenne and the Reims University Hospital. His research focuses on emergency care, infectious diseases, inflammatory biomarkers, and prehospital management of critically ill patients [1]. He has authored 55 documents indexed in Scopus, accumulating 1,267 citations and an h-index of 14 [2]. His work has contributed to clinical decision-making in emergency departments and the management of SARS-CoV-2 patients [7].

Abstract

This article examines the academic and clinical contributions of Stéphane Gennai, Professor of Universities – Hospital Practitioner at the University of Reims Champagne-Ardenne and the Reims University Hospital. His research addresses emergency medicine, infectious disease management, inflammatory biomarker prescriptions, and prehospital critical care [1]. With 55 Scopus-indexed documents, 1,267 citations, and an h-index of 14, his scholarly output supports evidence-based emergency practice [2]. His contributions have informed clinical decision-making, particularly in the management of SARS-CoV-2 patients and the use of risk-stratification models [7].

Keywords

  • Emergency Medicine, Inflammatory Biomarkers, SARS-CoV-2, Prehospital Care, Clinical Decision-Making, Antibiotic Prescriptions

Introduction

Stéphane Gennai is a prominent figure in French emergency medicine, currently serving as Head of the Emergency and Unscheduled Care Department at the Reims University Hospital since 2023 [1]. He has been affiliated with INSERM Unit UMR-S 1250 (Pulmonary Pathologies and Cellular Plasticity – P3Cell) since 2021 and has held the position of University Coordinator for Emergency Medicine in Champagne-Ardenne since 2019 [2]. His career spans clinical practice, research, and teaching, with a strong focus on improving emergency care through evidence-based research [3].

Research Profile

Stéphane Gennai’s research profile is characterized by a multidisciplinary approach, integrating emergency medicine with infectious diseases, epidemiology, and critical care. He obtained his Habilitation to Supervise Research (HDR) in 2021 and has been a PU-PH since 2022 [1]. His Scopus record includes 55 documents, 1,267 citations, and an h-index of 14, reflecting sustained scholarly impact in Medicine and Health Sciences [2]. He is also a member of the CPD Commission of the French Society of Emergency Medicine and Vice-President of the Grand Est College of Emergency Medicine [3].

Research Contributions

Stéphane Gennai has made significant contributions to emergency medicine research, particularly in the areas of inflammatory biomarker prescriptions, management of transient ischemic attacks, and prehospital care of critically ill patients [4]. His work on the revised HOME-CoV score has provided a risk-stratification model for patients with probable or proven COVID-19 in emergency departments [7]. He has also collaborated on studies evaluating osteopathic treatment for ankle sprains and the use of high-speed trains for mass transfers of critically ill patients [3] [4].

Publications

Stéphane Gennai’s publication record includes numerous peer-reviewed articles in high-impact journals. Notable contributions include the TRANSCOV cohort study on high-speed trains versus air transport for mass transfers of critically ill patients [3], and a study on early osteopathic treatment for acute lateral ankle sprains [4]. His work on smartphone dispatch applications for out-of-hospital cardiac arrest and the BASCULE study on triage in emergency departments further demonstrates his commitment to improving emergency care [5] [6].

Research Impact

The impact of Gennai’s research is evidenced by 1,267 citations and an h-index of 14, indicating that his work is frequently referenced by peers in emergency medicine and related fields [2]. His contributions to the management of SARS-CoV-2 in emergency departments have influenced clinical practice and policy, particularly through the validation of the HOME-CoV score [7]. His research on inflammatory biomarkers has also informed antibiotic stewardship and diagnostic strategies [1].

Award Suitability

Given his extensive research output, clinical leadership, and contributions to emergency medicine, Stéphane Gennai is a strong candidate for the Innovative Research Award at the Top Teachers Awards. His work has advanced the understanding and management of critical conditions in emergency settings, with measurable impact on patient care and clinical decision-making [1] [2]. His dedication to teaching and supervision further underscores his suitability for this recognition [3].

Conclusion

Stéphane Gennai’s career reflects a sustained commitment to advancing emergency medicine through rigorous research, clinical excellence, and education. His Scopus-recorded 55 documents, 1,267 citations, and h-index of 14 attest to his scholarly impact [2]. His contributions to the management of SARS-CoV-2, inflammatory biomarkers, and prehospital care have informed practice and policy, making him a deserving recipient of the Innovative Research Award [7].

References

  1. Elsevier. (n.d.). Scopus author details: Stéphane Gennai, Author ID 23093862000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=23093862000
  2. ORCID. (n.d.). Stéphane Gennai ORCID profile. ORCID.
    https://orcid.org/0000-0002-8490-4706
  3. Thipayamaskomon, C., Grimaud, O., Tattevin, P., Lamhaut, L., Leray, E., Letellier, N., Bayat, S., et al. (2026). High-speed trains versus air transport vectors for mass transfers of critically ill patients: The TRANSCOV cohort study. PLOS ONE.
    DOI: https://doi.org/10.1371/journal.pone.0348090
  4. Bournon, C., Prin-Conti, D., Douay, J., Montfajon, P. A., Kanagaratnam, L., & Gennai, S. (2026). Early osteopathic treatment delivered to patients with an acute lateral ankle sprain improves recovery: An investigative study. Journal of Osteopathic Medicine.
    DOI: https://doi.org/10.1515/jom-2025-0096
  5. Soumagnac, T., Soumagnac, M. T., Raphalen, J. H., Hutin, A., Lamhaut, L., Bossaert, C., Dolveck, F., et al. (2025). What to expect from a smartphone dispatch application for out-of-hospital cardiac arrest in a national population? Resuscitation.
    DOI: https://doi.org/10.1016/j.resuscitation.2025.110887
  6. Bilbault, P., Bronner, C., Etienne, A., Goudour, J., Dagtekin, S., Maire, B., Gennai, S., Chouihed, T., et al. (2025). BASCULE study: Is it possible to refer patients after triage in an emergency department to community medicine from a capacity standpoint for general medicine? Annales Françaises de Médecine d’Urgence.
    DOI: https://www.jle.com/10.1684/afmu.2025.0694
  7. Douillet, D., Riou, J., Morin, F., Mahieu, R., Chauvin, A., Gennai, S., Ferrant, L., Lopez, R., Sebbane, M., et al. (2024). Derivation and validation of a risk-stratification model for patients with probable or proven COVID-19 in EDs: The revised HOME-CoV score. Emergency Medicine Journal, 41(4), 218–225.
    DOI: https://doi.org/10.1136/emermed-2022-212805

Liliana Elena Weimer | Medicine and Health Sciences | Best Researcher Award

Published on by Top Teachers

Best Researcher Award

Liliana Elena Weimer
Italian National Institute of Health, Italy
Liliana Elena Weimer
Affiliation Italian National Institute of Health
Country Italy
Google Scholar 2q3g0CAAAAAJ
Documents 128
Citations 2,534
h-index 22
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
Scopus ID 6701388312
ORCID 0000-0002-1554-3150

Liliana Elena Weimer is a medical doctor and clinical researcher with over 30 years of experience in infectious diseases, clinical trials, and global health. Since 2022 she serves as First Researcher (Level II) at the Center for Global Health – Istituto Superiore di Sanità (ISS), Rome, Italy. Her career spans landmark HIV/HCV studies, COVID‑19 surveillance, Long‑COVID coordination, and international collaborations with WHO, the G20, and the American Clinical Trials Group.[1][2]

She has participated in national and multinational cohort studies, public health surveillance programs, and clinical research initiatives focused on infectious diseases and global health. As of September 2026, she has authored or co-authored more than 177 scientific publications and has contributed to research programs involving the American Clinical Trials Group, European collaborative projects, WHO-related activities, and Italian national surveillance systems. Her scholarly profile reflects sustained engagement in evidence-based medicine, public health research, and clinical investigation across several decades.[1][2]

Abstract

This article presents the academic and research profile of Dr. Liliana Elena Weimer, nominated for the Best Researcher Award in recognition of her outstanding contributions to clinical virology, public health surveillance, and international collaborative research. With a career spanning more than three decades at the Italian National Institute of Health (ISS), Dr. Weimer has coordinated national and multinational trials on HIV and HCV, contributed to the PITER cohort (25,000 patients), and led COVID‑19 and Long‑COVID surveillance protocols. Her work is characterised by high‑impact publications, a consistent h‑index of 22, and active engagement in European projects (ORCHESTRA, PREVENT Horizon, SHIELD). The nomination is supported by her record of public competition successes, teaching, and service with Doctors Without Borders.[1]

Keywords

Best Researcher Award, HIV/HCV clinical trials, PITER cohort, COVID‑19 surveillance, Long‑COVID, Malattie Infettive Long Covid, Doctor in Medicine, Infectious Diseases.

Introduction

The Best Researcher Award recognises individuals who demonstrate exceptional scientific output, leadership, and translational impact. Liliana Elena Weimer, MD, has built a distinguished career at the Istituto Superiore di Sanità (ISS), where she has been instrumental in shaping infectious disease research in Italy and beyond. Her work encompasses antiretroviral therapy optimisation, hepatitis C elimination strategies, and the establishment of national surveillance systems for HIV, HCV, and SARS‑CoV‑2. Notably, she is a member of the ISS COVID‑19 National Surveillance Group and the PITER study coordination team, and she contributes to WHO guidelines on Long‑Covid. Her international collaborations and sustained publication record make her a strong candidate for this award.[3]

Research Profile

Dr. Liliana Elena Weimer holds a medical degree from the University of Buenos Aires and a second MD from the University of L’Aquila, with specialisations in Infectious Diseases and Clinical Pharmacology. She has been a researcher at ISS since 1990, winning public competitions for fixed‑term, permanent, and First Researcher positions. Her research profile is characterised by a strong commitment to clinical epidemiology and trial methodology. She has contributed to landmark studies such as ACTG 384/388 (Italy‑USA AIDS trials), the PITER HCV cohort, and the European ORCHESTRA project. She also coordinates the national Long‑COVID surveillance protocol (2021‑2026) funded by the Italian Ministry of Health. With over 128 documents, 2,534 citations, and an h‑index of 22 (Scopus), she maintains a visible presence in the field.[2][4]

  • Senior Clinical Researcher at the Italian National Institute of Health (ISS), Rome.
  • More than three decades of experience in multicenter clinical trials and epidemiological research.
  • Collaborator with international HIV and HCV research networks.
  • Contributor to national SARS-CoV-2 and Long COVID surveillance programs.
  • Participant in European collaborative projects including ORCHESTRA, PREVENT Horizon, SHIELD, EURO-PERISTAT, and JA-05.
  • Member of professional organizations focused on infectious diseases and public health.

Research Contributions

Dr. Liliana Elena Weimer’s contributions are organised around three pillars: clinical trials and cohort studies, public health surveillance, and global health collaborations. She has coordinated over twenty national and international multicentre trials, including the Italian Protease Inhibitors Registry and the NIA surveillance network. As part of the PITER study, she contributed to the largest Italian HCV cohort (25,000 patients), informing treatment strategies for cirrhosis and hepatocellular carcinoma. During the COVID‑19 pandemic, she joined the ISS national surveillance group and collaborated with Bambino Gesù Pediatric Hospital, providing clinical and epidemiological support. She also serves as an external consultant for WHO’s Long‑Covid guidelines and is a member of the Brussels Network of Expertise on Long‑Covid.[5]

Liliana Elena Weimer’s research portfolio encompasses HIV treatment optimization, hepatitis C management, SARS-CoV-2 surveillance, and Long COVID characterization. Her participation in national cohort studies and international clinical trials has contributed to understanding treatment effectiveness, patient outcomes, and disease epidemiology.[1][3]

  • Clinical trials and cohort studies involving HIV therapies.
  • Research on HCV treatment outcomes and long-term virological response.
  • Investigation of monoclonal antibody strategies against emerging SARS-CoV-2 variants.
  • Long COVID symptom characterization and longitudinal follow-up studies.
  • Public health surveillance and antimicrobial resistance research.
  • Support for healthcare access initiatives in resource-limited settings.

Publications

Dr. Liliana Elena Weimer has authored or co‑authored more than 120 peer‑reviewed articles, book chapters, and monographs. Her work appears in high‑impact journals including Hepatology, Children, and Journal of Pediatrics Research Reviews. She received the Best Research Award from the journal Children (IF 2.5) for a study on the clinical characterisation of adolescents with Long‑COVID. She has also published two books on post‑COVID sequelae and SARS‑CoV‑2 variants. Below is a selection of her most cited works:

  • Morgan TR, Ghany MG, Kim HY, Snow KK, Shiffman ML, De Santo JL, … Weimer LE (2010). Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology, 52(3):833‑844.
  • George SL, Bacon BR, Brunt EM, Mihindukulasuriya KL, Hoffmann J, … Weimer LE (2009). Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‑year follow‑up of 150 patients. Hepatology, 49(3):729‑738.
  • Saxena V, Nyberg L, Pauly M, Dasgupta A, Nyberg A, Piasecki B, … Weimer LE (2015). Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis. Hepatology, 62(3):715‑725.

Research Impact

With over 2,534 citations and an h‑index of 22, Dr. Liliana Elena Weimer’s work has shaped clinical practice in hepatitis C and HIV care. Her studies on sustained virologic response and long‑term outcomes after HCV therapy are frequently cited in guidelines. She has received multiple recognitions, including an Abstract of Distinction at the AASLD Liver Meeting (2018) and the 2025 Best Research Award from Children journal. She was a Special Invitee to the G20 Health Summit 2023 and serves as a lay judge at the Court of Assizes in Rome. Her impact extends beyond academia: she is a volunteer with Doctors Without Borders (since 1992), providing AIDS therapies in Brazil, and actively participates in public health emergency responses.[1][3]

Award Suitability

The Best Researcher Award recognises sustained excellence, and Dr. Liliana Elena Weimer’s trajectory exemplifies this. She has won three public competitions at the ISS (fixed‑term, permanent, and First Researcher), demonstrating peer‑reviewed career progression. She coordinates the national PITER HCV cohort and the Long‑COVID surveillance protocol, and she has contributed to WHO guidelines. Her publication record includes landmark articles in hepatology, and she has received journal‑level awards for her work on Long‑COVID. Her international collaborations with the American Clinical Trials Group, INSERM, and the European Commission place her among the leading clinical researchers in Italy. This award would further acknowledge her role in translating research into public health action.[4]

Conclusion

Dr. Liliana Elena Weimer is a medical researcher of high calibre, with a career that bridges clinical trials, epidemiological surveillance, and global health equity. Her work on HIV, HCV, and COVID‑19 has informed national and international guidelines, and her commitment to service—through Doctors Without Borders and public health emergencies—distinguishes her as a compassionate and effective leader. The data presented—128 documents, 2,534 citations, h‑index 22, and consistent recognition—support her nomination for the Best Researcher Award. Her profile aligns with the core values of the award: scientific rigor, translational impact, and dedication to improving human health.[5]

References

  1. Scopus. (n.d.). Author details: Weimer, Liliana Elena, Author ID 6701388312. Scopus Preview.https://www.scopus.com/pages/authors/6701388312
  2. Google Scholar. (n.d.). Liliana Elena Weimer – citations & h‑index. Google Scholar.https://scholar.google.co.uk/citations?user=2q3g0CAAAAAJ
  3. Morgan, T. R., Ghany, M. G., Kim, H. Y., Snow, K. K., Shiffman, M. L., De Santo, J. L., … & Weimer, L. E. (2010). Outcome of sustained virological responders with histologically advanced chronic hepatitis C. Hepatology, 52(3), 833‑844. https://doi.org/10.1002/hep.23744
  4. George, S. L., Bacon, B. R., Brunt, E. M., Mihindukulasuriya, K. L., Hoffmann, J., … & Weimer, L. E. (2009). Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‑year follow‑up of 150 patients. Hepatology, 49(3), 729‑738. https://doi.org/10.1002/hep.22694
  5. Saxena, V., Nyberg, L., Pauly, M., Dasgupta, A., Nyberg, A., Piasecki, B., … & Weimer, L. E. (2015). Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis. Hepatology, 62(3), 715‑725. https://doi.org/10.1002/hep.27922

Saksham Kohli | Health Professions | Best Researcher Award

Published on by Top Teachers

Best Researcher Award

Saksham Kohli
Cook County Health

Saksham Kohli
Affiliation Cook County Health
Country United States
Scopus ID 59495632900
Documents 52
Citations 4
Subject Area Health Professions
Event Top Teachers Awards
ORCID 0000-0001-6983-1804

The Best Researcher Award recognition highlights the scholarly activities and emerging research contributions of Saksham Kohli at Cook County Health. Working within the field of Health Professions, Saksham Kohli has contributed to studies involving gastroenterology, hepatology, nephrology, and healthcare outcomes research. Recent publications demonstrate engagement with evidence-based clinical investigations addressing inpatient outcomes, quality improvement methodologies, readmission patterns, and patient survival analyses.[1] Through interdisciplinary research and participation in contemporary clinical studies, Saksham Kohli has supported the advancement of knowledge relevant to healthcare quality, patient management, and population-level medical outcomes.[2]

Abstract

This article presents an academic overview of Saksham Kohli and the research profile associated with recognition under the Best Researcher Award category. The researcher’s recent scholarly output focuses on clinical outcomes, gastrointestinal diseases, healthcare quality assessment, and patient-centered investigations. Published studies have addressed metabolic dysfunction-associated liver disease, endoscopy performance evaluation, alcoholic hepatitis readmissions, and survival considerations among elderly dialysis patients.[2]

Keywords

Health Professions, Gastroenterology, Clinical Outcomes Research, Healthcare Quality Improvement, Hepatology, Readmission Studies, Evidence-Based Medicine.

Introduction

Healthcare research plays a significant role in improving clinical practice, patient outcomes, and healthcare system efficiency. Researchers working across medical specialties contribute to evidence generation that supports informed decision-making and policy development. Saksham Kohli’s published work reflects participation in studies examining disease burden, treatment outcomes, healthcare utilization, and quality improvement initiatives within contemporary clinical settings.[3]

Research Profile

Affiliated with Cook County Health in the United States, Saksham Kohli has developed a research profile centered on applied clinical investigations. Indexed under Scopus Author ID 59495632900, the researcher has contributed to publications spanning gastroenterology, hepatology, nephrology, and healthcare analytics. These studies demonstrate engagement with real-world healthcare datasets and outcome-oriented medical research.[1]

Research Contributions

The research contributions of Saksham Kohli include analyses of metabolic-dysfunction-associated steatotic liver disease and its impact on inpatient outcomes, assessments of endoscope tip angulation performance, nationwide evaluations of alcoholic hepatitis readmissions, and investigations involving elderly dialysis populations.[2] These studies contribute to clinical understanding by examining patient outcomes, healthcare quality metrics, and disease management strategies using quantitative methodologies.[4]

Publications

  • Impact of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD) and Steatohepatitis (MASH) on Clostridioides difficile Inpatient Outcomes.
  • Quantitative Assessment of Endoscope Tip Angulation Performance in New Endoscopes.
  • Trends, Predictors, and Outcomes of 30- and 90-Day Readmissions Following Alcoholic Hepatitis.
  • Octogenarians on Dialysis; Navigating Survival Amidst Struggles.

Research Impact

The available publication record demonstrates contributions to clinically relevant topics affecting patient care and healthcare delivery. Research addressing liver disease outcomes, readmission risk factors, endoscopic performance, and nephrology-related survival outcomes provides useful evidence for healthcare professionals and researchers seeking to improve treatment effectiveness and quality standards.[5]

Award Suitability

Saksham Kohli’s profile aligns with the objectives of the Best Researcher Award through demonstrated scholarly engagement, publication activity, and contributions to healthcare research. The combination of outcome-based studies, quality improvement initiatives, and multidisciplinary clinical investigations reflects an active commitment to advancing medical knowledge and evidence-based practice.[1]

Conclusion

Saksham Kohli has contributed to a growing body of healthcare research through studies addressing important clinical and quality-of-care challenges. The published work demonstrates involvement in contemporary medical investigations and supports the dissemination of evidence relevant to patient outcomes, healthcare systems, and disease management. These accomplishments provide a foundation for recognition within academic and professional research communities.

References

  1. Elsevier. (n.d.). Scopus author details: Saksham Kohli, Author ID 59495632900. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59495632900
  2. Kohli, S. et al. (2026). Impact of MASLD and MASH on Clostridioides difficile Inpatient Outcomes.
    https://doi.org/10.3390/gastroent17020038
  3. Kohli, S. et al. (2026). Quantitative Assessment of Endoscope Tip Angulation Performance in New Endoscopes.
    https://doi.org/10.1055/a-2877-9452
  4. Kohli, S. et al. (2026). Trends, Predictors, and Outcomes of 30- and 90-Day Readmissions Following Alcoholic Hepatitis.
    https://doi.org/10.3390/gidisord8020027
  5. Kohli, S. et al. (2025). Octogenarians on Dialysis; Navigating Survival Amidst Struggles.
    https://doi.org/10.34172/jnp.2024.21476
  6. Top Teachers Awards. (n.d.). Best Researcher Award Recognition Program.
    topteachers.net

Song Guo Zheng | Medicine and Health Sciences | Best Innovator Award

Published on by Top Teachers

Best Innovator Award

Song Guo Zheng
Shanghai Jiao Tong University, China
Song Guo Zheng
Affiliation Shanghai Jiao Tong University
Country China
Scopus ID 7403146499
Documents 262
Citations 16,675
h-index 75
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-5611-4774
Google Scholar 37kvQ18AAAAJ

Song Guo Zheng is a physician-scientist and immunologist whose academic career has spanned molecular immunology, rheumatology, autoimmunity, cell therapy, and translational medicine. His research has contributed to the understanding of regulatory T cells, immune tolerance, autoimmune disease mechanisms, and therapeutic immunomodulation. He currently serves as Chair Professor of Medicine and Dean of the School of Cell and Gene Therapy at Shanghai Jiao Tong University School of Medicine while maintaining extensive leadership roles in international scientific organizations and scholarly publishing.[1]

Abstract

This article evaluates the academic achievements, scientific leadership, educational service, and innovation record of Song Guo Zheng in relation to the Best Innovator Award. His work integrates fundamental immunology with translational medicine, resulting in influential publications, patents, edited books, international collaborations, and leadership positions across major scientific societies. The breadth of his contributions demonstrates sustained impact on biomedical research and clinical immunology.[1]

Keywords

Rheumatology, Immunology, Autoimmunity, T Regulatory Cells, Cell Therapy, GMSC, Tumor Immunity.

Introduction

Over several decades, Song Guo Zheng has established an interdisciplinary research program focused on immune regulation, autoimmune disease pathogenesis, regenerative medicine, and therapeutic cell engineering. His academic development includes medical training in China, doctoral education in France, and faculty appointments at major institutions in the United States and China. His scientific output has contributed to both theoretical and applied aspects of immunological science.[1]

Research Profile

Song Guo Zheng earned an M.D. from Anhui Medical University and later completed a Ph.D. in Molecular Immunology at the University of Orleans, France. His academic appointments have included leadership roles at the University of Southern California, Penn State University, Ohio State University, and Shanghai Jiao Tong University. He has also served as editor, associate editor, and editorial board member for numerous high-impact journals while participating in major international grant-review panels and scientific committees.[1]

Research Contributions

  • Advanced understanding of regulatory T-cell biology and immune tolerance mechanisms.[2]
  • Developed strategies for immune modulation relevant to autoimmune disorders and inflammatory diseases.[3]
  • Contributed to translational research in cell therapy, tumor immunity, and regenerative medicine.
  • Secured multiple granted patents involving regulatory T cells, exosome applications, and immunotherapeutic technologies.[1]
  • Edited scientific books and chapters that support education and dissemination of immunological knowledge.

Publications

Representative publications include influential studies on regulatory T-cell induction, immune tolerance, vitamin-mediated immune regulation, and chronic disease immunobiology. These works have become widely cited within immunology and rheumatology literature.[2][3][4][5][6]

Research Impact

According to the provided scholarly metrics, the researcher has produced 262 indexed documents, accumulated more than 16,675+ citations, and achieved an h-index of 75. These indicators reflect substantial scholarly visibility and influence within biomedical sciences. His leadership in international societies, conference organization, editorial service, and research mentoring further extends the impact of his work beyond publication metrics alone.[1]

Award Suitability

The Best Innovator Award recognizes individuals who demonstrate sustained innovation, measurable research impact, educational leadership, and translational achievement. Song Guo Zheng’s portfolio includes pioneering immunological discoveries, numerous patents, extensive publication activity, scientific leadership, international recognition, and contributions to medical education. These accomplishments collectively support strong consideration for recognition within innovation-focused academic award programs.[1]

Conclusion

Song Guo Zheng has developed a distinguished career characterized by innovation in immunology, leadership in academic medicine, and contributions to translational biomedical research. His scientific achievements, educational service, publication record, patents, and international professional engagement provide a substantial foundation for recognition under the Best Innovator Award framework.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Song Guo Zheng, Author ID 7403146499. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7403146499
  2. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity. The Journal of Immunology. https://doi.org/10.4049/jimmunol.172.9.5213
  3. Huang Z, Liu Y, Qi G, Brand D, Zheng SG. Role of Vitamin A in the Immune System. Journal of Clinical Medicine. https://doi.org/10.3390/jcm7090258
  4. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.178.4.2018
  5. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation Ex Vivo of TGF-β-Producing Regulatory T Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.169.8.4183
  6. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, Zheng SG. Vitamin D and Chronic Diseases. Aging and Disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC5440113/

Faiza Abou El-Soud | Nursing and Health Professions | Research Excellence Award

Published on by Top Teachers

Research Excellence Award

Faiza Abou El-Soud
King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Saudi Arabia
Faiza Abou El-Soud
Affiliation King Saud bin Abdulaziz University for Health Sciences (KSAU-HS)
Country Saudi Arabia
Scopus ID 58296844700
Documents 3
Citations 18
h-index 3
Subject Area Nursing and Health Professions
Event Top Teachers Awards
ORCID 0000-0002-2897-7249

Faiza Abou El-Soud is a nursing educator, researcher, and academic leader whose professional contributions span more than three decades in the fields of community health nursing, geriatrics nursing, nursing education, and public health advancement. Her scholarly and educational work has focused on curriculum development, evidence-based nursing education, health promotion initiatives, and community-oriented healthcare strategies. Through her extensive teaching portfolio and institutional leadership roles, she has contributed to the advancement of nursing competencies and interdisciplinary healthcare education across academic institutions in Egypt, the United Arab Emirates, and Saudi Arabia.[1]

Abstract

This article presents a scholarly overview of the academic career, educational leadership, research engagement, and professional contributions of Faiza Abou El-Soud within the field of nursing and health sciences. Her work reflects long-standing engagement in community health nursing, geriatric healthcare, public health education, curriculum innovation, and academic mentorship. Across institutions in Egypt, the United Arab Emirates, and Saudi Arabia, she has contributed to nursing education through evidence-based instructional methodologies, interdisciplinary collaboration, faculty development initiatives, and research supervision. Her participation in professional conferences, institutional committees, international workshops, and healthcare outreach programs further demonstrates sustained contributions to healthcare education and community well-being.[2]

Keywords

Community Health Nursing, Nursing Education, Health Promotion, Geriatrics Nursing, Public Health, Curriculum Development, Evidence-Based Education, Nursing Research, Healthcare Leadership, Women’s Health, Self-Care, Health Risk Assessment, Academic Administration.

Introduction

The discipline of nursing education continues to evolve in response to global healthcare challenges, demographic transitions, and advancements in patient-centered care practices. Academic professionals who integrate teaching excellence with community engagement and scholarly inquiry contribute significantly to healthcare systems and institutional development. Within this context, Faiza Abou El-Soud has maintained a distinguished academic career focused on strengthening nursing education, promoting public health awareness, and fostering interdisciplinary healthcare learning environments.[3]

Her academic background includes a Bachelor’s degree in Nursing Sciences from Cairo University, a Master’s degree in Community Health Nursing from Menoufia University, and a Doctorate in Community Health Nursing from Menoufia University. Her educational progression established a foundation for later contributions in nursing pedagogy, curriculum reform, healthcare assessment methodologies, and community-centered educational programs.[4]

Throughout her professional trajectory, Faiza Abou El-Soud has held faculty and leadership positions across multiple universities, contributing to undergraduate and postgraduate nursing programs while supporting accreditation initiatives, quality assurance processes, and research-oriented educational practices. Her career reflects integration between academic instruction, healthcare advocacy, and applied nursing research.[5]

Research Profile

Faiza Abou El-Soud specializes in community health nursing with additional emphasis on geriatric nursing, health promotion, disease prevention, women’s health, caregiver support, self-care practices, and health education. Her academic profile reflects extensive involvement in nursing research methodologies, public health interventions, epidemiology, and healthcare curriculum enhancement.[6]

She has contributed to the supervision of master’s and doctoral students in areas including maternal and neonatal outcomes, obesity and pregnancy, hemodialysis-related quality of life, sleep disturbance in hospitalized patients, and community health nursing interventions. These supervisory activities demonstrate active participation in graduate-level research mentorship and scholarly development.[7]

Her professional responsibilities have also included service on research committees, scientific review panels, curriculum development committees, and institutional advisory groups. In addition, she has served as a reviewer for nursing and healthcare journals indexed in international databases, contributing to scholarly peer-review processes and academic publication quality standards.[8]

  • Community Health Nursing and Population-Based Healthcare
  • Women’s Health and Maternal Care Education
  • Health Promotion and Disease Prevention Strategies
  • Curriculum Development and Nursing Pedagogy
  • Research Methodology and Statistical Applications
  • Healthcare Simulation and Active Learning Approaches

Research Contributions

Faiza Abou El-Soud has participated in numerous academic projects and institutional initiatives aimed at improving healthcare education and nursing practice. Her collaborative involvement in projects supported by ministries of higher education and health authorities addressed areas such as nursing curriculum restructuring, faculty evaluation quality, family health training, and competency-based nursing education.[9]

She also contributed to the implementation of active learning environments through Problem-Based Learning (PBL), Team-Based Learning (TBL), clinical simulation methodologies, and competency-oriented assessment frameworks. These educational strategies have become increasingly important within healthcare training institutions due to their emphasis on critical thinking and evidence-based clinical reasoning.[10]

Her academic service includes participation in international conferences, scientific workshops, and healthcare seminars addressing nursing education, geriatric healthcare, epidemiology, research dissemination, healthcare simulation, and public health promotion. Such involvement reflects sustained engagement with professional development and interdisciplinary healthcare dialogue.

  • Co-investigator in Higher Education Enhancement Project Fund (HEEPF)
  • Educational Consultant for Promoting Quality Faculty Evaluation for Nurses’ Students in Clinical Environments (PQFE)
  • Research supervision in maternal health, obesity, hemodialysis, and nursing quality-of-life studies
  • Reviewer for nursing and health sciences journals indexed in international academic databases
  • Contributor to community health awareness programs and nursing outreach activities

Publications

The scholarly publication record associated with Faiza Abou El-Soud demonstrates research engagement within the fields of nursing education, healthcare outcomes, public health awareness, and evidence-based clinical practice. Her Scopus-indexed publications contribute to nursing scholarship and healthcare education literature through interdisciplinary perspectives and applied research methodologies.

  1. Research relating to maternal and neonatal healthcare outcomes and risk assessment methodologies.
  2. Studies involving health education strategies, nursing interventions, and patient-centered healthcare awareness.
  3. Academic contributions addressing curriculum development, nursing competency assessment, and evidence-based nursing instruction.

Relevant DOI-linked healthcare literature and nursing education frameworks further contextualize her areas of scholarly engagement within international nursing research standards.

Research Impact

The impact of Faiza Abou El-Soud’s academic work extends across teaching, curriculum development, healthcare awareness, and student mentorship. Her educational leadership within nursing programs has contributed to the preparation of healthcare professionals equipped with competencies in clinical reasoning, evidence-based practice, and community health engagement.

Her involvement in healthcare outreach programs, women’s health education, adolescent health awareness, first-aid training activities, and school health initiatives reflects sustained participation in community-centered healthcare promotion. These initiatives support preventive healthcare education and public awareness strategies within institutional and community settings.

The academic influence of her work is additionally reflected through faculty peer-review responsibilities, examination review activities, research supervision, and participation in accreditation-oriented educational reforms. Her role in mentoring nursing students and supervising graduate research contributes to the development of future healthcare educators and clinical practitioners.[16]

Award Suitability

Faiza Abou El-Soud’s professional profile demonstrates alignment with the objectives of the Top Teachers Awards through sustained excellence in nursing education, healthcare mentorship, curriculum leadership, and community-oriented academic service. Her contributions span teaching innovation, public health advocacy, research supervision, and interdisciplinary healthcare collaboration across multiple institutions and international contexts.

Her experience in curriculum enhancement, active learning implementation, healthcare simulation training, faculty development, and nursing research supervision reflects comprehensive engagement with modern healthcare education standards. Additionally, her participation in scientific conferences, editorial review activities, and institutional quality assurance initiatives illustrates continued scholarly and professional involvement.

The combination of academic longevity, healthcare service, research participation, educational mentorship, and community engagement supports recognition within academic excellence and healthcare education award frameworks.

Conclusion

Faiza Abou El-Soud represents a sustained academic and professional presence within nursing education and community healthcare advancement. Her work across teaching, curriculum development, healthcare research, graduate supervision, and public health engagement reflects a comprehensive commitment to nursing scholarship and educational quality. Through interdisciplinary collaboration, healthcare advocacy, and evidence-based instructional approaches, she has contributed meaningfully to the development of nursing education and healthcare awareness initiatives across diverse institutional settings.

References

  1. King Saud bin Abdulaziz University for Health Sciences. (n.d.). Faculty and academic professional profile documentation for Dr. Faiza Abou El-Soud. KSAU-HS.
  2. Elsevier. (n.d.). Scopus author details: Faiza Abou El-Soud, Author ID 58296844700. Scopus. https://www.scopus.com/authid/detail.uri?authorId=58296844700
  3. World Health Organization. (2021). State of the world’s nursing report. WHO Publications.
  4. Menoufia University. (n.d.). Academic qualifications and nursing education records. Egypt.
  5. American Association of Colleges of Nursing. (2021). The essentials: Core competencies for professional nursing education.
  6. International Council of Nurses. (2020). Nursing leadership and healthcare development frameworks.
  7. KSAU-HS College of Nursing. (n.d.). Graduate supervision and thesis mentorship activities.
  8. Elsevier. (2020). International Journal of Africa Nursing Sciences. https://doi.org/10.1016/j.ijans.2020.100275
  9. Ministry of Higher Education and Scientific Research. (2005). Higher Education Enhancement Project Fund (HEEPF) initiatives.
  10. Hmelo-Silver, C. E. (2004). Problem-based learning: What and how do students learn https://ijn.thebrpi.org/journals/ijn/Vol_5_No_2_December_2018/9.pdf

Yuki Hasegawa | Bioelectronics and Biomaterials | Research Excellence Award

Published on by Top Teachers

Assoc. Prof. Dr. Yuki Hasegawa | Bioelectronics and Biomaterials | Research Excellence Award

Saitama University | Japan

Assoc. Prof. Dr. Yuki Hasegawa research focuses on advancing sensor technology and measurement systems with strong emphasis on gas sensors, taste sensors, electrochemical sensing, and plant bioelectrical potential measurement for environmental and agricultural applications. Core contributions include the design, fabrication, and evaluation of functional material–based sensors and miniaturized sensing platforms capable of stable, sensitive, and reproducible measurements under real-world conditions. Innovative experimental methodologies and signal analysis techniques have been developed to improve sensor selectivity, long-term stability, and response reliability. Research outcomes support interdisciplinary applications spanning environmental monitoring, smart agriculture, and bio-sensing systems, enabling more accurate detection of chemical and biological signals. The work integrates electrical engineering principles with materials science and measurement engineering, contributing to scalable and practical sensing solutions. Findings have been disseminated through high-impact peer-reviewed international journals and conferences indexed in SCI/SCIE and Scopus, strengthening global knowledge exchange in sensing technologies. Scholarly impact is reflected through citation metrics, with 306 total citations (124 since 2020), an h-index of 9 (6 since 2020), and an i10-index of 9 (2 since 2020), demonstrating consistent research influence and relevance. Overall, the research advances next-generation sensing systems and supports sustainable technological development in environmental and agricultural engineering.

Citation Metrics (Google Scholar)

Total Citations
306

Citations: 306 |
h-index: 9 |
i10-index: 9

🟦 Citations    🟩 h-index    🟥 i10-index


View Google Scholar Profile

Featured Publications

Arriel Makembi Bunkete | Health Professions | Best Researcher Award

Published on by Top Teachers

Dr. Arriel Makembi Bunkete | Health Professions | Best Researcher Award

University of Kinshasa | Congo, Democratic Republic of the

Dr. Arriel Makembi Bunkete is a dedicated nephrologist and internal medicine specialist whose clinical and scientific work focuses on kidney transplantation, dialysis innovations, and the epidemiology of chronic kidney disease across diverse and resource-limited settings. He has developed a strong research identity through his contributions to transplant coordination, acute and chronic dialysis strategies, extracorporeal purification techniques, clinical nephrology, glomerular diseases, and the management of toxicological and environmental kidney injuries. His multidisciplinary approach integrates clinical practice, research leadership, and collaborative scientific work with teams in French Guiana, France, and the Democratic Republic of the Congo. Dr. Bunkete’s research addresses critical challenges such as anemia in kidney transplant recipients, sickle cell nephropathy, lupus nephritis activity, paraquat poisoning, high blood lead levels in dialysis patients, and the implementation of home hemodialysis in remote territories. His scientific output includes peer-reviewed articles, case reports, international conference abstracts, and involvement in ongoing epidemiological studies. Recognized for his growing academic influence, he has accumulated 4 citations, an h-index of 1, and an i10-index of 0 (Google Scholar metrics), with comparable citation performance indexed in Scopus. He also contributes as a reviewer for leading nephrology journals, reflecting his commitment to advancing global renal research. His work has received competitive research grant support for studies on APOL1 variants and chronic kidney disease in French Guiana, reinforcing his standing as an emerging investigator in tropical nephrology and transplant medicine. With a strong scientific footprint, ongoing research leadership, and steady scholarly growth, Dr. Bunkete demonstrates the qualities associated with the Best Researcher Award in nephrology.

Publication Profile

Google Scholar

Featured Publications

Bunkete, A. M. (2025). Home hemodialysis in French Guiana: Transforming logistical challenges into healthcare opportunities. Bulletin de la Dialyse à Domicile, 8(2), 107–111.

Kabasele, D. B., Bunkete, A. M., Mbayabo, G., Lumbala, P., Matondo, O., Aloni, M., et al. (2025). Hydroxyurea and regression of sickle cell nephropathy: Open clinical trial in a pediatric population in DR Congo. Kidney360.

Bunkete, A. M., Kasonga, P. K., Fermigier, F., & Djiconkpode, I. (2025). WCN25-137: Pediatric nephrology in French Guiana – Overview and outlook. Kidney International Reports, 10(2), S615.

Anga, K., Makembi, A., Amisi, É., Delpierre, É., Ha, V. H. T., Mbombo, W., et al. (2024). Morbidity and mortality of acute renal failure in COVID-19 patients in intensive care according to waves/variant: Case of the Grand Hôpital de l’Est Francilien site de Meaux. Open Journal of Internal Medicine, 14(1), 16–29.

Bunkete, A. M., Belgrine, M., Sidibe, M., Bellony, S., Davodun, T., Djiconkpode, I., et al. (2025). Dialyse péritonéale chez un nourrisson avec insuffisance rénale aiguë sévère: Dialyse réalisée en plein vol lors d’une évacuation sanitaire en Guyane – À propos d’un cas. Bulletin de la Dialyse à Domicile, 8(3), 255–261.

Liu Wenyi | Health Sciences | Best Researcher Award

Published on by Top Teachers

Dr. Liu Wenyi | Health Sciences | Best Researcher Award

Cancer Hospital Chinese Academy of Medical Sciences | China

Dr. Liu Wenyi is a thoracic-surgery specialist whose research focuses on advanced treatments for thoracic malignancies especially esophageal and lung cancers emphasising organ-preservation strategies, neoadjuvant chemo-/chemo-immunotherapy, imaging- and machine-learning-based response assessment, and translational biomarkers for surgical decision-making. His work has contributed to the evolving paradigm of less-invasive surgery and more personalised multimodal care. For example, his recent narrative review “Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions” is a state-of-the-field synthesis published in Cancers  highlighting novel surveillance-based approaches in esophageal squamous cell carcinoma. His Google Scholar/Scopus profile indicates approximately 10 publications and a current h-index of 5 (citations ~80) under his name. This volume reflects a mid-career emerging investigator whose trajectory is marked by high-impact topics (thoracic oncology, immunotherapy, AI-enabled imaging) and whose top publications already appear in high-visibility journals. Dr. Liu’s work is characterized by integrating minimally invasive surgical techniques, cutting-edge neoadjuvant systemic treatments and advanced predictive modelling to stratify patients for surgical risk and organ-sparing pathways thus contributing to both improved patient quality of life and optimized oncologic outcomes.His outstanding contributions to clinical innovation and scientific research excellence reflect strong merit for recognition under the Best Researcher Award .

Publication Profile

Orcid

Featured Publications

Liu, W., Guo, X., Zhao, H., Yu, X., Wang, C., Du, L., Wang, F., & Mu, J. (2020). Mediastinoscopy-assisted transhiatal esophagectomy versus thoraco-laparoscopic esophagectomy for esophageal cancer: A single-center initial experience. Journal of Thoracic Disease, 12(9), 4908-4914.

Liu, W., Tang, J., Li, X., Gong, L., Yang, D., Yin, H., Wang, W., & Zhang, B. (2025). Reduction in surgical scope after neoadjuvant chemotherapy and immunotherapy for non-small cell lung cancer. Oncology Letters, 30(5), 501.

Liu, W., Sui, Z., Wang, C., Deng, Y., Cai, S., Jia, R., Yu, Z., Kang, M., & Zhang, B. (2025). Nomogram for predicting pathological complete response to neoadjuvant chemoimmunotherapy in patients with resectable non-small cell lung cancer. Frontiers in Cell and Developmental Biology, 13, 1679782.

Hong, Z., Xie, S., Xu, H., Ke, S., Liu, W., Huang, S., Chen, S., Xie, J., Xu, J., & Kang, M. (2025). Major pathologic response as a prognostic surrogate in esophageal squamous cell carcinoma patients receiving neoadjuvant chemotherapy/chemoimmunotherapy: A multi-center cohort study. European Journal of Surgical Oncology, 51(2), 109500.

Liu, W., Zhang, B., Wang, C., Yu, X., Du, L., Yu, Z., & Kang, M. (2025). Organ Preservation in Esophageal Cancer: Current Strategies, Challenges, and Future Directions. Cancers, 17(21), 3559.

 

Tanjirul Islam | Public Health | Young Researcher Award

Published on by Top Teachers

Réla Bodea | Medicine| Best Researcher Award

Published on by Top Teachers